Tahoe Therapeutics · Series A

Tahoe Therapeutics, formerly Vevo Therapeutics, builds gigascale single-cell datasets to train

Amount

$30M

Round

Series A

Valuation

—

Announced

—

Investors

Participating investors

General Catalyst

Amplify Partners

Conviction Databricks Ventures Wing Venture Capital AIX Ventures Civilization Ventures Mubadala Capital Ventures